A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/00 (2006.01) A61K 48/00 (2006.01)
Patent
CA 2263503
The invention pertains to a method of treating or protecting against melanoma that comprises (a) obtaining a melanoma cell line that expresses one or more shared immunodominant melanoma antigens, (b) modifying the melanoma cell line to render it capable of producing an increased level of a citokyne relative to the unmodified cell line, and (c) administering the melanoma cell line to a mammalian host that has melanoma or is at risk for developing melanoma. Preferably the melanoma cell line is allogenic and is not MHC-matched to the host.
Cette invention a trait à des méthodes thérapeutiques ou prophylactiques à l'encontre de mélanomes consistant, (a), à obtenir une lignée cellulaire exprimant un ou plusieurs antigènes hétérophiles immunodominants du mélanome, (b), à modifier la lignée cellulaire du mélanome pour la rendre capable de produire davantage de cytokine que ne le ferait une lignée cellulaire non modifiée et (c), à administrer cette lignée cellulaire à un mammifère hôte porteur d'un mélanome ou risquant d'en développer un. Cette lignée cellulaire qui est, de préférence, allogénique, n'est pas associée à l'hôte en fonction du complexe majeur d'histocompatibilité.
Adler Adam
Jaffee Elizabeth M.
Pardoll Drew M.
Rosenberg Steven A.
Topalian Suzanne L.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
The Johns Hopkins University School Of Medicine
United States Of America Represented By The Secretary Of The Department Of Health And Hum
LandOfFree
Melanoma cell lines expressing shared immunodominant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanoma cell lines expressing shared immunodominant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanoma cell lines expressing shared immunodominant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1551564